Journal ArticleAnnual review of biomedical engineering · July 2024
Kidney disease is a global health crisis affecting more than 850 million people worldwide. In the United States, annual Medicare expenditures for kidney disease and organ failure exceed $81 billion. Efforts to develop targeted therapeutics are limited by a ...
Full textCite
Journal ArticleTrends in pharmacological sciences · April 2023
Chronic kidney disease (CKD) is an epidemic that affects millions worldwide. The glomerulus, a specialized unit of the nephron, is highly susceptible to injury. Human induced pluripotent stem cells (iPSCs) have emerged as an attractive resource for modelin ...
Full textCite
Journal ArticleJournal of visualized experiments : JoVE · November 2022
Chronic kidney disease (CKD) affects 15% of the U.S. adult population, but the establishment of targeted therapies has been limited by the lack of functional models that can accurately predict human biological responses and nephrotoxicity. Advancements in ...
Full textCite
Journal ArticleCell stem cell · August 2020
COVID-19 has unfortunately halted lab work, conferences, and in-person networking, which is especially detrimental to researchers just starting their labs. Through social media and our reviewer networks, we met some early-career stem cell investigators imp ...
Full textOpen AccessCite
Journal ArticleJournal of visualized experiments : JoVE · July 2020
Kidney disease affects more than 10% of the global population and costs billions of dollars in federal expenditures. The most severe forms of kidney disease and eventual end-stage renal failure are often caused by the damage to the glomerular podocytes, wh ...
Full textOpen AccessCite
Journal ArticleNature protocols · July 2018
Protocols have been established to direct the differentiation of human induced pluripotent stem (iPS) cells into nephron progenitor cells and organoids containing many types of kidney cells, but it has been difficult to direct the differentiation of iPS ce ...
Full textCite
Journal ArticleNature biomedical engineering · January 2017
An in vitro model of the human kidney glomerulus - the major site of blood filtration - could facilitate drug discovery and illuminate kidney-disease mechanisms. Microfluidic organ-on-a-chip technology has been used to model the human proximal tubul ...
Full textCite
Chapter · January 2015
The ultimate goal of most biomedical research is to gain greater insight into mechanisms of human disease or to develop new and improved therapies or diagnostics. Although great advances have been made in terms of developing disease models in animals, such ...
Full textCite
Journal ArticleProceedings of the National Academy of Sciences of the United States of America · September 2014
Physical stimuli can act in either a synergistic or antagonistic manner to regulate cell fate decisions, but it is less clear whether insoluble signals alone can direct human pluripotent stem (hPS) cell differentiation into specialized cell types. We previ ...
Full textCite
Journal ArticleACS nano · November 2012
Reaping the promise of human embryonic stem (hES) cells hinges on effective defined culture conditions. Efforts to identify chemically defined environments for hES cell propagation would benefit from understanding the relevant functional properties of the ...
Full textCite
Journal ArticleJournal of the American Chemical Society · February 2010
Synthetic materials that promote the growth or differentiation of cells have advanced the fields of tissue engineering and regenerative medicine. Most functional biomaterials are based on a handful of peptide sequences derived from protein ligands for cell ...
Full textCite
Journal ArticleElectroanalysis · January 1, 2007
The nature and extent of the interactions of phytoestrogens such as quercetin (Q) with monophosphate nucleotides have implications in cell cycle arrest, DNA damage, and inhibition of intracellular enzymes involved with cell proliferation. We have studied t ...
Full textCite